Skip to search.
 FTSE 100 Down 0.12%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
10.05 Down 0.21(2.05%) 20 Apr 21:00
|After Hours: : 10.05 0.00 (0.00%) 20 Apr 23:03
Add to Portfolio
Prev Close:10.26
Open:10.27
Bid:10.00 x 300
Ask:10.31 x 2900
1y Target Est:17.44
Beta:1.41
Earnings Date:5 May - 11 May (Est.)
Day's Range:10.03 - 10.30
52wk Range:2.45 - 16.87
Volume:1,989,189
Avg Vol (3m):4,702,400
Market Cap:1.18b
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNDown 2.05%1.18b
GSKDown 0.40%113.30b
JNJUp 0.63%278.63b
RHHBYUp 0.51%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.95
Quarterly EPS Est (Mar-15) :-0.22
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback